|
|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 121 - 150 of 372 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
PL
|
Resepti
|
Cefepim MIP Pharma 1 g, 2 g injektio-infuusiokuiva-aine, liuosta varten SPC 2021-11-10
|
|
PL
|
Resepti
|
Cefotaxim MIP Pharma 1 g, 2 g injektio-infuusiokuiva-aine liuosta varten SPC 2021-11-24
|
|
PL
|
Resepti
|
Ceftazidim Fresenius Kabi 1000 mg injektiokuiva-aine, 2000 mg injektio-infuusiokuiva-aine liuosta varten SPC 2021-11-24
|
|
PL
|
Resepti
|
Ceftazidim MIP Pharma 1 g, 2 g injektio-infuusiokuiva-aine liuosta varten SPC 2022-01-04
|
|
PL
|
Resepti
|
Ceftriaxon Copyfarm 1g injektiokuiva-aine ja 2g infuusiokuiva-aine SPC 2010-01-06
|
|
PL
|
Resepti
|
Ceftriaxon Fresenius Kabi 1 g injektio-infuusiokuiva-aine, liuosta varten SPC 2021-10-13
|
|
PL
|
Resepti
|
Ceftriaxon Fresenius Kabi 2 g infuusiokuiva-aine, liuosta varten SPC 2021-10-13
|
|
PL
|
Resepti
|
Ceftriaxon MIP Pharma 1 g injektio-infuusiokuiva-aine liuosta varten, 2 g infuusiokuiva-aine, liuosta varten SPC 2021-11-22
|
|
PL
|
Resepti
|
Ceftriaxon Navamedic 1 g injektiokuiva-aine, liuosta varten, 2 g infuusiokuiva-aine, liuosta varten SPC 2023-09-06
|
|
PL
|
Resepti
|
Ceftriaxone Kalceks 1 g, 2 g injektio-infuusiokuiva-aine, liuosta varten SPC 2024-05-01
|
|
PL
|
Resepti
|
Cefuroxim MIP Pharma 750 mg, 1500 mg injektio-infuusiokuiva-aine liuosta varten SPC 2023-05-25
|
|
PL
|
Resepti
|
Cefuroxim Navamedic 250 mg, 750 mg, 1500 mg injektio-/infuusiokuiva-aine liuosta varten SPC 2023-12-29
|
|
PL
|
Resepti
|
Cefuroxim Stragen 250 mg injektiokuiva-aine, liuosta varten ja 750 mg,1.5 g injektio-infuusiokuiva-aine, liuosta varten SPC 2023-05-01
|
|
PL
|
Resepti
|
Cefuroxime Kalceks 750 mg, 1500 mg injektio-infuusiokuiva-aine liuosta varten SPC 2023-10-10
|
|
PL
|
Resepti
|
Cefuroxime Orion Pharma 750 mg, 1.5 g injektio-infuusiokuiva-aine, liuosta-suspensiota varten SPC 2023-01-26
|
|
|
|
European Medicines Agency's website:
Cegfila - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Celdoxome pegylated liposomal - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Celebra 100 mg, 200 mg kapseli, kova SPC 2022-02-09
|
|
PL
|
Resepti
|
Celecoxib Krka 100 mg, 200 mg kapseli, kova SPC 2022-01-19
|
|
PL
|
Resepti
|
Celecoxib Sandoz 100 mg, 200 mg kapseli, kova SPC 2020-11-27
|
|
PL
|
Resepti
|
Celecoxib Stada 100 mg, 200 mg kapseli, kova SPC 2021-05-06
|
|
PL
|
Resepti
|
Celecoxib Viatris 100 mg, 200 mg kapseli, kova SPC 2022-06-10
|
|
PL
|
Resepti
|
Celeston Chronodose 3+3 mg-ml injektioneste, suspensio SPC 2021-10-11
|
|
PL
|
Resepti
|
Celiprolol Vitabalans 200 mg, 400 mg tabletti, kalvopäällysteinen SPC 2021-03-17
|
|
|
|
European Medicines Agency's website:
CellCept - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Itsehoito
|
Celluvisc 1.0 % silmätipat, liuos, kerta-annospakkaus SPC 2022-03-16
|
|
|
|
European Medicines Agency's website:
Celsentri - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Celsunax - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Cemisiana 0.03 mg - 2 mg tabletti, kalvopäällysteinen SPC 2022-10-21
|
|
|
|
European Medicines Agency's website:
Ceplene - EMA: EPAR PI
Finnish Swedish
|
|
|
| |
